EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Antimalarial efficacy monitoring after nearly 20 years of artemisinin-based combination therapy in Africa: recalibrating guidance

Leah F Moriarty, Maria M Betoulle, Peter Troell, Irene Cavros, Kevin Griffith, Mateusz M Plucinski

Trends in Parasitology · 2026-06 · 42 (6) · 445-453

DOI: 10.1016/j.pt.2026.02.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Parasitology, 2026-06. Verfasst von Leah F Moriarty und 5 weiteren Autor:innen. Beteiligte Einrichtung: Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: wvp4@cdc.gov. Hauptthemen laut MEDLINE: Artemisinins, Antimalarials, Drug Resistance, Malaria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Timely identification of resistance to antimalarials is necessary to ensure effective malaria case management. The backbone of antimalarial resistance surveillance strategies is the therapeutic efficacy study (TES). Originally designed to be easily deployable, in recent years, TES have become increasingly complex and slow to yield results. Concurrently, advances in molecular surveillance techniques, the emergence and spread of artemisinin partial resistance in Africa, and advances in antimalarial drug stewardship through multiple first-line therapies have changed the context in which TES are implemented. In this opinion article, we outline considerations for recalibrating TES methodology. More efficient TES, coupled with molecular surveillance, could provide timely and actionable data for malaria-endemic countries as they manage treatment policies in the context of drug resistance in Africa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsAntimalarialsDrug ResistanceMalariaHumansAfricaDrug Therapy, Combination

Stichwörter der Autor:innen

antimalarial resistancemalariatherapeutic efficacy study

Substanzen

ArtemisininsAntimalarialsartemisinin

Autor:innen und Institutionen

  • Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: wvp4@cdc.gov.
  • Laboratory Science and Diagnostics Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Independent Consultant, Durango, CO, USA.

Zitieren

APA

Moriarty, L. F., Betoulle, M. M., Troell, P., Cavros, I., Griffith, K., & Plucinski, M. M. (2026). Antimalarial efficacy monitoring after nearly 20 years of artemisinin-based combination therapy in Africa: recalibrating guidance. Trends in Parasitology, 42(6), 445-453. https://doi.org/10.1016/j.pt.2026.02.012

Vancouver

Moriarty LF, Betoulle MM, Troell P, Cavros I, Griffith K, Plucinski MM. Antimalarial efficacy monitoring after nearly 20 years of artemisinin-based combination therapy in Africa: recalibrating guidance. Trends in Parasitology. 2026;42(6):445-453. doi:10.1016/j.pt.2026.02.012

BibTeX
@article{Moriarty2026,
  author = {Moriarty, Leah F and Betoulle, Maria M and Troell, Peter and Cavros, Irene and Griffith, Kevin and Plucinski, Mateusz M},
  title = {Antimalarial efficacy monitoring after nearly 20 years of artemisinin-based combination therapy in Africa: recalibrating guidance},
  journal = {Trends in Parasitology},
  year = {2026},
  volume = {42},
  number = {6},
  pages = {445--453},
  doi = {10.1016/j.pt.2026.02.012}
}
Kostenlos starten →